Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm(3)

BACKGROUND: Co-infection with Mycobacterium tuberculosis remains a leading cause of morbidity and mortality among HIV infected individuals especially in developing countries. Early initiation of cART in these patients when CD4+ T cell count is less than 200cells/mm(3) has reduced disease progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutembo, Simon, Mutanga, Jane N., Musokotwane, Kebby, Alisheke, Lutangu, Whalen, Christopher C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067898/
https://www.ncbi.nlm.nih.gov/pubmed/27751168
http://dx.doi.org/10.1186/s12879-016-1916-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067898/
https://www.ncbi.nlm.nih.gov/pubmed/27751168
http://dx.doi.org/10.1186/s12879-016-1916-1

Ejemplares similares